LEADER 03387nam  22005415  450 
001 9910337492703321
005 20200704075532.0
010   $a3-030-00362-0
024 7 $a10.1007/978-3-030-00362-3
035   $a(CKB)4100000007334859
035   $a(DE-He213)978-3-030-00362-3
035   $a(MiAaPQ)EBC5626879
035   $a(PPN)232964513
035   $a(EXLCZ)994100000007334859
100   $a20181227d2019      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAggressive Lymphomas /$fedited by Georg Lenz, Gilles Salles
205   $a1st ed. 2019.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019.
215   $a1 online resource (VII, 360 p. 70 illus., 65 illus. in color.) 
225 1 $aHematologic Malignancies,$x2197-9766
311   $a3-030-00361-2 
327   $aPART I: Epidemiology, Pathology and molecular Pathogenesis: Epidemiology -- Pathology and molecular pathogenesis of DLBCL and related entities -- Pathology and molecular pathogenesis of Burkitt lymphoma and lymphoblastic lymphoma -- Pathology and molecular pathogenesis of T-cell lymphoma -- Part III: Future directions in aggressive lymphomas: Role of modern imaging in aggressive lymphoma -- Kinase inhibitors -- Immunologic approaches -- Other novel targeted therapies -- How biology will help guiding our treatment decisions?.
330   $aThis book summarizes current knowledge of the biology and molecular pathogenesis of aggressive lymphomas and reviews the state of the art in diagnostic and therapeutic strategies. The aim is both to provide the reader with a sound understanding of the very significant progress that has been achieved in the understanding and management of these malignancies over recent years and to facilitate appropriate choice of the therapeutic strategy in individual cases. The assessment of different prognostic parameters are clearly presented in order to permits effective risk stratification that impacts on treatment choice. Recent insights into lymphomagenesis are exemplified and may assist in identifying emerging therapeutic targets. The comprehensive and up-to-date nature of the book will make it an ideal reference for all physicians and researchers interested in lymphoma, including clinicians from various medical specialties, biologists, pathologists, radiologists and nuclear medicine specialist, as well as students.
410  0$aHematologic Malignancies,$x2197-9766
606   $aHematology
606   $aPathology
606   $aImmunology
606   $aHematology$3https://scigraph.springernature.com/ontologies/product-market-codes/H3307X
606   $aPathology$3https://scigraph.springernature.com/ontologies/product-market-codes/H4800X
606   $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000
615  0$aHematology.
615  0$aPathology.
615  0$aImmunology.
615 14$aHematology.
615 24$aPathology.
615 24$aImmunology.
676   $a616.15
702   $aLenz$b Georg$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aSalles$b Gilles$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910337492703321
996   $aAggressive Lymphomas$91734919
997   $aUNINA